Get Permission Parida and Sen: Pyoderma gangrenosum in tuberculosis: A rare association


Introduction

Tuberculosis still continues to puzzle physicians with its myriad manifestations and associations. Pyoderma gangrenosum is one of such unusual associations. In around 50 % of the cases with pyoderma gangrenosum an underlying disease or a predisposing factor is found. 1 Being an inflammatory neutrophilic dermatosis itself its association with tuberculosis is not common and only 10 cases with tuberculosis with an associated pyoderma gangrenosum have been reported so far. 2 Here in, we present a case of tuberculous pleural effusion doing well on anti-tubercular therapy until he developed pyoderma gangrenosum requiring appropriate management with immunosuppressant.

Case Report

A 50 year old male without any comorbidities presented with high grade fever and rapidly progressing skin lesions over arms and legs for 12 days. He was a diagnosed case of left tuberculous effusion on regular follow up and in the third month of antitubercular treatment with good clinicoradiological response (Figure 1, Figure 2) On examination he had a pulse rate of 90/ minute, blood pressure of 110/70 mm Hg, respiratory rate of 24 /minute and with an oxygen saturation of 99% at room air. His temperature was 102.4 degrees F. On examination there were multiple tender circular skin lesions with size around 4 cm X 4.6 cm over arms and legs with hemorrhagic crusting and necrotic bluish margins with undermined edges and associated with joint pain as well (Figure 3 ). All other systems were normal on examination except for a reduced vesicular breath sound over left infrascapular area. As per advice of dermatologists the patient underwent biopsy from the skin lesions which showed keratinized stratified squamous epithelium showing large areas of ulceration and marked folliculitis surrounded by dense polymorphs suggestive of pyoderma gangrenosum. His anti-tubercular treatment was continued and he was started on systemic steroids followed by addition of cyclosporine later to which he responded favorably (Figure 4). A written consent was taken from the patient for utilizing his clinical data and investigations.

Figure 1

Chest X ray showing left sided pleural effusion at the onset of antitubercular treatment

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/0cda336a-d5d6-4842-8a15-a9e8529465dfimage1.png
Figure 2

Chest X ray showing improvement during the course of treatment

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/0cda336a-d5d6-4842-8a15-a9e8529465dfimage2.png
Figure 3

Circular skin lesion with hemorrhagic crusting and necrotic margins

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/0cda336a-d5d6-4842-8a15-a9e8529465dfimage3.png
Figure 4

Resolution of skin lesions on follow up

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/0cda336a-d5d6-4842-8a15-a9e8529465dfimage4.png

Discussion

Pyoderma gangrenosum is a neutrophilc dermatosis without a clear etiology and a diagnosis of exclusion. It begins as pustule or a vesicopustule and progresses to an ulcer with suppuration. It can be associated with numerous conditions like inflammatory bowel disease and other autoimmune disorders as well as hematological malignancies.1 They can be drug induced too. 3 There are 10 reported cases of pyoderma gangrenosum associated with tuberculosis at various sites. They include testicular TB, 4 abdominal TB,5 osteoarticular, 6 TB lymphadentis, 1, 3 pulmonary TB. 6, 7, 8 disseminated TB(8). Our case being tuberculous pleural effusion further adds to the this limited list of case reports of tuberculosis being associated with pyoderma gangrenosum.

As pyoderma gangrenosum is a diagnosis of exclusion when it occurs in the setting of tuberculosis it becomes very important to differentiate it from cutaneous TB, ATT induced drug rash and exclusion of all other conditions like coexisting malignancy and autoimmune disorder. This is also one of the many conditions in tuberculosis where immunosuppressant are used along with ATT and thus requires careful monitoring.

Conclusions

In pyoderma gangrenosum apart from looking for chronic inflammatory conditions and malignancies a detailed work up to exclude any form of TB should be helpful given the high prevalence of TB in India. Further research needs to direct to help making a diagnosis and establish association between these two clinical entities.

Acknowledgements

Dr. Bhabani Shankar Tarini Prasad Singh, Assistant Professor, Department of Skin and VD, IMS and SUM Hospital.

Conflict of Interest

The authors declare no conflict of interest.

Source of Funding

None.

References

1 

C Ollivier C Bernigaud B Bonsang N Ortonne B Nebbad R Lepeule Pyoderma gangrenosum et tuberculose : une association méconnueAnn de Dermatol et de Vénéréologie2019146A28510.1016/j.annder.2019.09.465

2 

SE Kadiri S Elloudi Z Douhi H Baybay FZ Mernissi A Douida Pyoderma Gangrenosum and Multifocal Tuberculosis: Is it a True Association?Sci J Clin Res Dermatol20216146

3 

I Zaraa A Hawilo S B Hassine I Chelly S Haouet M Mourad Pyoderma Gangrenosum and lymph nodes tuberculosis disease: unusual association Dermatol Rep201131e810.4081/dr.2011.e8

4 

F Antón Botella, JL Peña Somovilla J Salcedo Aguilar JM Turón Alcaine A Ruiz Valverde JM Campo Hernandez Pioderma gangrenosum asociadoa tuberculosis testicularAn Med Interna1989610549

5 

N Y Kim J Y Choi K H Lee J W Shin Pyoderma gangrenosum in a patient with colonic tuberculosisAm J Gastroenterol199489812579

6 

S Nanoudis A Tsona O Tsachouridou P Morfesis G Loli A Georgiou Pyoderma gangrenosum in a patient with chronic granulomatous disease: A case reportMedicine (Baltimore)20179631e771810.1097/MD.0000000000007718

7 

M Matsui E Ohtoshi J Yamaoka N Matsuyoshi K Ohta K Toda Cutaneous tuberculosis and pyoderma gangrenosumInt J Dermatol2000391384010.1046/j.1365-4362.2000.00843.x

8 

K Romańska-Gocka C Cieścińska B Zegarska R A Schwartz J Cieściński D Olszewska-Słonina Pyoderma gangrenosum with monoclonal IgA gammopathy and pulmonary tuberculosis. Illustrative case and reviewPostepy Dermatol Alergol20153221374110.5114/pdia.2014.40974



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 20-08-2022

Accepted : 14-09-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/ 10.18231/j.ijirm.2022.032


Article Metrics






Article Access statistics

Viewed: 650

PDF Downloaded: 393